Johanna Mercier
Johanna Mercier is a prominent executive at Gilead Sciences, serving as the Chief Commercial and Corporate Affairs Officer. She has played a critical role in advancing the company's strategic partnerships and initiatives aimed at improving global health outcomes, particularly in the field of HIV prevention and treatment. Mercier's leadership was highlighted in a recent agreement with the Pan American Health Organization (PAHO) to expand access to lenacapavir, a long-acting HIV prevention drug, in Latin America and the Caribbean, reflecting her commitment to public health and collaborative efforts to combat the HIV epidemic.
Global Media Ratings
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| Jamaica | 1 | 8.00 | 0.33% | +0% | 2,961,167 | 9,677 | $15,000 | 49$ |
| Totals | 1 | 2,961,167 | 9,677 | $15,000 | 49$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Jamaica:
Johanna Mercier is the chief commercial and corporate affairs officer at Gilead Sciences.
8